Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

Exclusion Criteria

• •1. Any systemic or antibiotics (injected or oral) within 6 months of starting study
• •2. Any topical antibiotic or benzoyl peroxide within 1 month of starting study or any subject unwilling to refrain from washout of topical antibacterial or benzoyl peroxide ingredient.
• •3. No intake of alcohol or tea throughout the duration of the study.
• •4. No more than 1 8 oz cup of coffee per week throughout the duration of the study.
• •5. No more than 1 cup of berries (strawberries, blueberries, raspberries, blackberries, etc.) per week throughout the duration of the study.
• •6. No intake of pomegranate, or pomegranate-containing drinks throughout the duration of the study.
• •7. No intake of chocolate (in any form) throughout the duration of the study.
• •8. No more than 1 cup of fermented dairy products per week throughout the duration of the study.
• •9. Any oral probiotic or prebiotic supplementation within past 1 month
• •10. Subjects must have no history of malignancy or cancer or diagnosis of gastrointestinal inflammatory diseases, no history or diagnosis of epilepsy, no history or diagnosis of immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid arthritis)
• •11. Has a condition or is on medication the investigator and/or designee believe could jeopardize the safety of the subject, interfere with the evaluation, or confound the interpretation of the study results
• •12. Women who have been pregnant in the last three months, are pregnant, preparing to be pregnant or lactating.
• •13. Is participating in a concurrent clinical research study or has participated in an acne or other facial study at this or any other facility in the past 4 weeks
• •14. Those with BMI higher than 35 kg/m²
• •15. Commencement of a new diet (such as the ketogenic diet) or supplements within the 1 month prior to initiating participation, at the discretion of the investigator.
• •16. Use of medications that alter blood lipids, such as statins and anti-hyperlipidemic medications
• •17. Is participating in or has participated in a facial study at this or any other facility in the past 4 weeks. Participation in survey-based studies are approved at the discretion of the investigator.
• •18. Has a skin disease on face that will interfere with image collection and assessment in the opinion of the investigator
• •19. Refusal to shave or remove facial hair that may interfere with image collection and assessment.
• •20. Persons unwilling to avoid the following during the 4 weeks prior and during the duration of the study: self-tanning, spa tanning, sun tanning, or artificial tanning.
• •21. Planned vacation to sunny destination with the intention of sun tanning during the duration of the study.
• •22. Persons who regularly undergo sauna treatments (dry or wet) or who swim daily.
• •23. Known allergy or irritation to the supplement or facial products utilized in the study
• •24. Current tobacco smokers, OR those that have smoked tobacco over the past year, OR a 5 year-pack year history of smoking tobacco
• •25. Prisoners
• •26. Adults unable to consent
• •27. Vegans